Bonora, B. M., Raschi, E., Avogaro, A., & Fadini, G. P. (2021). SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system. Cardiovasc Diabetol.
استشهاد بنمط شيكاغوBonora, Benedetta Maria, Emanuel Raschi, Angelo Avogaro, و Gian Paolo Fadini. "SGLT-2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System." Cardiovasc Diabetol 2021.
MLA استشهادBonora, Benedetta Maria, Emanuel Raschi, Angelo Avogaro, و Gian Paolo Fadini. "SGLT-2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System." Cardiovasc Diabetol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.